Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01990664 · ClinicalTrials.gov registry record · NA

Clinical Evaluation of Lapsed Contact Lens Wearers Who Are Re-fit Into Senofilcon A Contact Lenses

A NA study, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
199
Enrollment target

NCT01990664: Completed NA study, sponsored by Johnson & Johnson Vision Care.

NCT01990664 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 199 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01990664, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
199 participants
Enrollment target

Study Summary

This study is an open-label, multi-site study. The total number of subjects was 200. The duration of this study was approximately four weeks. The primary objective was to assess what percentage of lapsed contact wearers, who have discontinued use of their contact lenses for greater than six months can be successfully re-fit with senofilcon A, reusable 2-weekly replacement daily wear lenses (spherical and toric designs).

Primary Outcome

Percentage of lapsed contact wearers who were successfully refitted among subjects who have lapsed from contact lens use more than 6 months prior to the date of enrollment in the study. Successful fit was assessed by on eye care practitioner (ECP) judgment of acceptable physiology.

Interventions

  • DEVICE senofilcon A
  • DEVICE senofilcon A for Astigmatism

Trial Details

FieldValue
Enrollment Target 199 participants
Start Date 2013-11
Est. Completion 2014-04
Phase NA
Johnson & Johnson Vision Care

142 total trials

What the finished NCT01990664 record still lists

NCT01990664 is an interventional study that assigns participants to a tested intervention. The registered 199 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 2 interventions - of which senofilcon A is the first listed.

NCT01990664 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01990664 about?

NCT01990664 is a clinical study titled "Clinical Evaluation of Lapsed Contact Lens Wearers Who Are Re-fit Into Senofilcon A Contact Lenses". This study is an open-label, multi-site study. The total number of subjects was 200. The duration of this study was approximately four weeks. The primary objective was to assess what percentage of lapsed contact wearers, who have discontinued use of their contact lenses for greater than six months c...

What is the current status of trial NCT01990664?

This trial is currently completed. It is a NA study. The enrollment target is 199 participants. The study started on 2013-11. Estimated completion is 2014-04.

What interventions are being tested in trial NCT01990664?

The interventions under investigation include: senofilcon A (DEVICE), senofilcon A for Astigmatism (DEVICE).

Who is sponsoring clinical trial NCT01990664?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01990664's enrollment target sits among peer trials

199 567th of 2000 higher than 1,434 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04312126 · 199 participants

    The Beneficial Effects of Naps on Motor Learning

  • NCT04951622 · 199 participants · Phase 3

    A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

  • NCT06474533 · 199 participants

    Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01990664, the US trial registry maintained by the National Library of Medicine. NCT01990664 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.